regulatory status raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-04-05. Anything still debated is marked as such rather than presented as settled.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
=== Turbulence === Turbulence is the time-dependent chaotic behaviour seen in many fluid flows. It is generally believed that it is due to the inertia of the fluid as a whole: the culmination of time-dependent and convective acceleration; hence flows where inertial effects are small tend to be laminar (the Reynolds number quantifies how much the flow is affected by inertia). It is believed, though not known with certainty, that the Navier–Stokes equations describe turbulence properly. The numerical solution of the Navier–Stokes equations for turbulent flow is extremely difficult, and due to the significantly different mixing-length scales that are involved in turbulent flow, the stable solution of this requires such a fine mesh resolution that the computational time becomes significantly infeasible for calculation or direct numerical simulation. Attempts to solve turbulent flow using a laminar solver typically result in a time-unsteady solution, which fails to converge appropriately. To counter this, time-averaged equations such as the Reynolds-averaged Navier–Stokes equations (RANS), supplemented with turbulence models, are used in practical computational fluid dynamics (CFD) applications when modeling turbulent flows. Some models include the Spalart–Allmaras, k–ω, k–ε, and SST models, which add a variety of additional equations to bring closure to the RANS equations. Large eddy simulation (LES) can also be used to solve these equations numerically.
Among the extreme claims used to market goji berries or its juice, often referred to as a "superfruit", is the unsupported story that a Chinese man named Li Qing Yuen, who was said to have consumed wolfberries daily, lived to the age of 256 years (1677–1933). This claim originated in a 2003 booklet by Mindell, who also claimed goji had anti-cancer properties. The booklet contained false and unverified claims. On 29 May 2009, a class action lawsuit was filed against FreeLife in the United States District Court of Arizona. This lawsuit alleged false claims, misrepresentations, false and deceptive advertising, and other issues regarding FreeLife's Himalayan Goji Juice, GoChi, and TaiSlim products. This lawsuit sought remedies for consumers who had purchased the products over the years. A settlement agreement was reached on 28 April 2010, where FreeLife took steps to ensure that its goji products were not marketed as "unheated" or "raw", and made a contribution to an educational organization. As with many other novel "health" foods and supplements, the lack of clinical evidence and poor quality control in the manufacture of consumer products prevent goji from being clinically recommended or applied.
Yessotoxins are a group of lipophilic, sulfur bearing polyether toxins that are related to ciguatoxins. They are produced by a variety of dinoflagellates, most notably Lingulodinium polyedrum and Gonyaulax spinifera. When the environmental conditions encourage the growth of YTX producing dinoflagellates, the toxin(s) bioaccumulate in edible tissues of bivalve molluscs, including mussels, scallops, and clams, thus allowing entry of YTX into the food chain.
Once on the membrane, the various adaptors would work together to package different types of cargo into the newly forming vesicle. Robinson and her researchers use several approaches to look for novel adaptors and other components of the trafficking machinery, including proteomic analyses of sub cellular fractions, genome-wide siRNA library screening, insertional mutagenesis, and a new method they developed for rapidly inactivating proteins, called 'knock sideways'. Her current projects include establishing the functions of AP-1 and other adaptors in differentiated cells; matching up machinery and cargo proteins; investigating how clathrin and adaptors are hijacked by the HIV-1-encoded protein Nef; determine why mutations in the non-clathrin adaptors AP-4 and AP-5 cause hereditary spastic paraplegia; and exploring the evolution of adaptors. Her laboratory uses many techniques including immunolocalisation at the light and electron microscope levels, sub cellular fractionation, protein purification, proteomics, flow cytometry, live cell imaging, and X-ray crystallography.
Sources: en.wikipedia.org
For services to Child Road Safety. Kenneth Fitzpatrick. Lifeboat Operations Manager, Porthdinllaen Lifeboat Station, Royal National Lifeboat Institution. For services to Maritime Safety. Barry Flack. For services to the Jewish Community in the London Borough of Barnet. Margaret Elizabeth Flanagan. Member, Inner Wheel Club of Ballymena. For voluntary services to the community in Ballymena, County Antrim. John Campbell Forrester. President and Poppy Appeal Organiser, Driffield Branch, Royal British Legion. For voluntary service to Veterans in East Yorkshire. Claire Forsythe. Duke of Edinburgh's Award Officer, Probation Board for Northern Ireland. For services to the Rehabilitation of Offenders. Susan Joan Foster. For voluntary service in Hampshire. Richard Charles Fowler. Library Lead, Harbury Community Library, Warwickshire. For services to Libraries. Dr Jennifer Ann Frow. Volunteer, Bewdley Tennis Club. For services to Lawn Tennis in Worcestershire. Robert Francis Fyfe. Chair and Director, Runway Theatre Company. For services to the Arts and to the community in Glasgow. Melanie Jane Gardner. Fine and Decorative Arts Curator, Tullie House Museum, Carlisle. For services to Arts and Culture in Cumbria. Joseph William Garvey. For services to the community in County Armagh. Peter William Garwood. For services to the community in Barrow-in-Furness, Cumbria. Christine Frances Gatfield. Founder, Dove Cottage Day Hospice. For services to the Terminally Ill. Patricia Mary Gaywood. Membership Secretary, The Forty Club. For voluntary service to Cricket. Andrew Gell.
== Advantages and disadvantages == This laboratory technique has various advantages. First, these tests are relatively cheap, relatively straightforward and allow for real-time measurements. Additionally, the testing conditions can be easily adjusted to fit different experimental objectives. This approach also allows for a strong directional migratory response making quantifying data simple. One limitation of this assay is that there could be inconsistencies with the depth and size of the scratch. When the scratch is done manually, it's susceptible to 'ragged' edge boundaries, which make analyzing data more difficult. Also, the damage could physically damage the cells adjacent to the wound and create inaccurate wound size areas. This limitation is slowly becoming less of an issue with automated technologies. The Electric Cell Impendance Sensing assays utilize to prevent damage to the cells in the underlying extracellular matrix that can likely happen with the manual scratching approaches. Additionally, the Woundmaker makes fast and uniform wounds across various numbered well-plates options (96 or 384) and allows for high throughput screening, which is a major advantage for various medical research studies. Despite the new technology that is increasing this assay's accuracy and efficacy, there are still confounding factors that can skew the assay results, such as cell "crowding", cell/cell adhesion effects and matrix effects. Additionally, there is still mention with the problem of accumulation of cells at the edge of the scratch, making the cell densities uneven.
The French Second Republic (French: Deuxième république française or La IIe République), officially the French Republic (République française), was the second republican formation of the government of France. The republic existed from 1848, when the monarchy fell, until its dissolution only four years later in 1852 upon the proclamation of the Second French Empire. Following the final defeat of Napoleon Bonaparte at the Battle of Waterloo, in June 1815, France had been reconstituted into a monarchy known as the Bourbon Restoration. After a brief period of revolutionary turmoil in 1830, royal power was again secured in the "July Monarchy", governed under principles of moderate conservatism and improved relations with the United Kingdom. In 1848, Europe erupted into a mass revolutionary wave in which many citizens challenged their royal leaders. Much of it was led by France in the February Revolution, overthrowing King Louis-Philippe. Radical and liberal factions of the population convened the French Second Republic in 1848. Attempting to restore the First French Republic's values on human rights and constitutional government, they adopted the motto of the First Republic; Liberté, Égalité, Fraternité. The republic was plagued with tribalist tendencies of its leading factions: royalists, proto-socialists, liberals, and conservatives. In this environment, Napoleon's nephew, Louis-Napoléon Bonaparte, established himself as a popular anti-establishment figure and was elected president in 1848.
British businessmen Hamish Harding and Shahzada Dawood, along with Dawood's son, Suleman, are confirmed as being aboard the missing submersible that disappeared during a voyage to see the wreck of the RMS Titanic two days earlier. 21 June – UK inflation figures for May 2023 show it remained higher than expected, at 8.7%. 22 June The Bank of England raises the official bank rate from 4.5% to 5%, the 13th consecutive rise, and a greater increase than economists had expected. The RMT announces three fresh days of strike action for 20, 22 and 29 July. 23 June Banks and building societies are summoned for a meeting with Jeremy Hunt as pressure grows on them to help people struggling with rising mortgage costs. A series of measures are agreed, offering more flexibility. Junior doctors in England announce a new five-day walkout from 13 to 18 July – the longest strike yet – over pay. Following a trial at Northampton Crown Court, Louis De Zoysa is convicted of the 2020 murder of police sergeant Matt Ratana. 24 June – The UK government holds an emergency COBRA meeting to discuss the Wagner Group rebellion in Russia. Sunak urges both sides to "be responsible and to protect civilians". 25 June A national technical fault affects the 999 service, meaning emergency services are unable to receive calls for around two hours. The service is fully restored by the evening. A spokesman for Sarah, Duchess of York says that she is recovering following surgery for breast cancer at King Edward VII's Hospital a few days earlier.
=== High-throughput proteomic technologies === Proteomics has steadily gained momentum over the past decade with the evolution of several approaches. Few of these are new, and others build on traditional methods. Mass spectrometry-based methods, affinity proteomics, and micro arrays are the most common technologies for large-scale study of proteins.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.